BiBBInstruments AB

Equities

BIBB

SE0010102095

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
4.78 ^SEK	+0.42%		+2.80%	+51.27%

May. 03	BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	BiBBInstruments Secures Patent for EndoDrill in India	MT

Bibbinstruments AB Announces First US Clinical Cases Successfully Conducted with Endodrill GI

February 02, 2024 at 07:56 am EST

BiBBInstruments AB announced that the first US clinical procedures with EndoDrill® GI have successfully been performed by Dr Antonio Mendoza Ladd and his team at UC Davis Health, Sacramento, California. BiBB received 510(k) clearance from the US FD for EndoDrill® GI in 2023 and clinical marketing activities will continue in the US.

Latest news about BiBBInstruments AB

BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03	CI
BiBBInstruments Secures Patent for EndoDrill in India	Apr. 18	MT
BiBBInstruments AB Announces Successful Clinical Pilot Study with EndoDrill GI Published in Peer Reviewed Scientific Journal	Apr. 17	CI
BiBBInstruments Reports First Clinical Procedures in Sweden with Endoscopic Biopsy Instrument	Apr. 05	MT
Bibbinstruments AB First Clinical Tissue Acquisition Procedures with Endodrill® Gi At Karolinska University Hospital in Stockholm Have Been Successfully Performed	Apr. 05	CI
BiBBInstruments Wins Japanese Patent for Biopsy System	Feb. 21	MT
BiBBInstruments AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 10	CI
BiBBInstruments AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 10	CI
BiBBInstruments Obtains European CE Certification for Endoscopic Biopsy Instrument	Feb. 07	MT
BiBBInstruments Reports First US Clinical Procedures with Core Needle Biopsy System	Feb. 02	MT
Bibbinstruments AB Announces First US Clinical Cases Successfully Conducted with Endodrill GI	Feb. 02	CI
BiBBInstruments AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
BiBBInstruments Secures European Patent for Cancer Diagnostic Product	23-09-05	MT
Bibb Receives Approval of Two Patents in Europe for Endodrill	23-09-05	CI
BiBBInstruments AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
BiBBInstruments AB Reports Positive Results from Clinical Pilot Study with EndoDrill URO	23-06-07	CI
BiBBInstruments AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-19	CI
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
BiBBInstruments AB Receives Another Intention to Grant Notice for EndoDrill in Europe	23-03-07	CI
BiBBInstruments AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
BiBBInstruments AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
BiBBInstruments Aims for US Market Entry in 2023	22-06-23	CI
BiBBInstruments Develops the CE-Marked Electromechanical Biopsy Instruments for Endoscopic Use	22-05-13	CI
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-06	CI
BiBBInstruments AB announced that it has received SEK 21.6 million in funding from Tibia Konsult Aktiebolag, Creades AB, Gainbridge Capital AB, Aktia Fund Management Company Ltd	22-02-07	CI

Chart BiBBInstruments AB

Duration

Period

More charts

Company Profile

BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio includes EndoDrill GI Upper for stomach biopsy, EndoDrill GI Lower for intestinal biopsy, EndoDrill GI Lung for lung biopsy, EndoDrill Therapy to pass displacements in different organs for placement of conductors, balloons and stents for treatment, EndoDrill Needle for breasts biopsy, as well as EndoDrill Model X for multiple areas and falls under independent research project. Products are distributed to hospitals with endoscopy specialistsâ centers and surgical wards. The Companyâs primary distribution focus is Scandinavian countries.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BIBBINSTRUMENTS AB	+51.27%	11.67M
SARTORIUS AG	-12.09%	19.25B
QUIDELORTHO CORPORATION	-39.00%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.02%	1.96B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.62%	1.69B
BIOTAGE AB	+33.51%	1.27B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.17%	982M
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.01%	913M
REVENIO GROUP OYJ	+5.38%	801M
VAREX IMAGING CORPORATION	-23.80%	630M

Medical Diagnostic & Testing Equipment